Clinical Trial Signals · weekly
Newly posted recruiting studies with US sites, every week.
Studies first posted on ClinicalTrials.gov in the past week and listed as recruiting, grouped by state and lead sponsor, with the site, phase, conditions and a link to each official record.
Free one-week sample by reply. Email hello@enrollfeed.com with the states and therapy areas you cover.
- Minnesota
- Study of Modzatinib (ATI-2138) in Adult Participants With Biopsy-proven Forms of Lichen Planus Not Adequately Controlled With Topical TherapiesPhase 2Aclaris Therapeutics, Inc. · New Brighton
- Repurposing Insulin With Intranasal Administration to Improve Function After Mild Traumatic Brain InjuryPhase 2HealthPartners Institute · Saint Paul
- Advanced Imaging-Guided Standard Versus Dose-Intensified Radiation Therapy for the Treatment of Newly Diagnosed Glioblastoma, SAGA 2.0 TrialPhase 3Mayo Clinic · Albert Lea
- Florida
- Ph 1 Study Long-acting Interleukin-7, Efineptakin Alfa, to Enhance Immune Reconstitution After PTCyPhase 1H. Lee Moffitt Cancer Center and Research Institute · Tampa
What's newly recruiting, sorted the way you staff it.
Only what's new
Studies first posted in the past week, listed as recruiting, with at least one US site listed as recruiting.
By state, then sponsor
Each recruiting site sits under its state and lead sponsor, with facility, city, phase and conditions.
From the public record
Source: ClinicalTrials.gov. Every row links to the official record and every list shows the registry's data date. No contact names, phone numbers or emails.
This week's list, shortened
Nov 13–20: 39 newly posted studies listed as recruiting, 51 US recruiting sites across 24 states, 38 lead sponsors. Below are real rows from that build.
- Window
- First posted Nov 13–20, 2026
- Delivery
- Weekly by email, Monday by default
- Source
- ClinicalTrials.gov public records; no contact details
| Study | Phase | Conditions | Recruiting site | First posted | Site status |
|---|---|---|---|---|---|
| Minnesota6 sites | |||||
| Aclaris Therapeutics, Inc. | |||||
| Study of Modzatinib (ATI-2138) in Adult Participants With Biopsy-proven Forms of Lichen Planus Not Adequately Controlled With Topical TherapiesNCT07935590 | Phase 2 | Lichen Planus | Aclaris Clinical SiteNew Brighton | Nov 13 | Recruiting |
| HealthPartners Institute | |||||
| Repurposing Insulin With Intranasal Administration to Improve Function After Mild Traumatic Brain InjuryNCT07935278 | Phase 2 | Concussion (Diagnosis), Mild Traumatic Brain Injury | HealthPartners Neuroscience CenterSaint Paul | Nov 13 | Recruiting |
| Mayo Clinic | |||||
| Advanced Imaging-Guided Standard Versus Dose-Intensified Radiation Therapy for the Treatment of Newly Diagnosed Glioblastoma, SAGA 2.0 TrialNCT07935889 | Phase 3 | Glioblastoma, IDH-Wildtype | Mayo Clinic Health System in Albert LeaAlbert Lea | Nov 13 | Recruiting |
| Mayo Clinic Health Systems-MankatoMankato | Nov 13 | Recruiting | |||
| Mayo Clinic Radiation Therapy - NorthfieldNorthfield | Nov 13 | Recruiting | |||
| Mayo Clinic in RochesterRochester | Nov 13 | Recruiting | |||
| Florida5 sites | |||||
| H. Lee Moffitt Cancer Center and Research Institute | |||||
| Ph 1 Study Long-acting Interleukin-7, Efineptakin Alfa, to Enhance Immune Reconstitution After PTCyNCT07940738 | Phase 1 | Hematologic Malignancy | Moffitt Cancer CenterTampa | Nov 17 | Recruiting |
| RAI Services Company | |||||
| Vuse Pro Puffing Topography Study in Adult SmokersNCT07938320 | Not applicable | Smoking, Tobacco | WACDoral | Nov 16 | Recruiting |
| L&E Research TampaTampa | Nov 16 | Recruiting | |||
| Trevi Therapeutics | |||||
| A Study of the Potential Pharmacokinetic Interaction Between Quinidine Sulfate and Nalbuphine Extended-Release Tablets (NAL ER) in Healthy ParticipantsNCT07946575 | Phase 1 | Healthy Participants | Clinical Pharmacology of Miami, LLCMiami | Nov 18 | Recruiting |
| University of Florida | |||||
| RNA Lipid Particles Targeting Pediatric Recurrent Intracranial Malignancies and Other systEmic Solid Tumors - High Grade GliomaNCT07949071 | Phase 1, Phase 2 | Recurrent High-grade Glioma | UF HealthGainesville | Nov 19 | Recruiting |
| Texas5 sites | |||||
| Carnegie Mellon University | |||||
| AI-Driven Hip Exoskeleton Control for Diverse Users and Walking TasksNCT07940127 | Not applicable | Healthy Volunteers, Gait … | University of Texas at AustinAustin | Nov 16 | Recruiting |
| + 4 more sites in this state in the full list | |||||
Showing 12 of 51 US recruiting sites. Listed as recruiting as of Nov 20, 2026; may have changed since, check the official record (the NCT link on each row). We don't yet show status changes or newly added sites; those need weekly snapshots to compare.
Data from ClinicalTrials.gov, a U.S. government database. Registry data timestamp: Nov 20, 2026, 10:00:05 (as published; the field has no time zone). Processed: Nov 20, 2026, 3:02 PM ET. Our changes: we keep only studies first posted in the window that are listed as recruiting with at least one US site listed as recruiting, keep only those US sites, group them by state and lead sponsor, shorten condition lists, drop contact details and withhold the names of individual sponsor-investigators. EnrollFeed is not affiliated with or endorsed by ClinicalTrials.gov, NLM or NIH. Sponsors and investigators are responsible for each record. Not medical or enrollment advice. How the list is built.
Simple monthly pricing
No free tier. We charge for selection, formatting and delivery, not for the ClinicalTrials.gov records. Monthly plan that renews automatically. Cancel anytime from the Stripe link in your receipt; cancellation takes effect at the end of the paid period. Refund of your first charge on request within 7 days. US buyers only.
Individual
One recipient.
- The weekly list by email, Monday by default
- Grouped by state and lead sponsor, with a link to each NCT record
- Data timestamp and processing date on every issue
Charges appear on your card statement as OTE Jobs.
Team
Up to 3 people at one organization.
- Everything in Individual
- Up to 3 recipients
Charges appear on your card statement as OTE Jobs.
Free one-week sample by reply. Email hello@enrollfeed.com with the states and therapy areas you cover.
Questions
What is in the list?
Studies first posted on ClinicalTrials.gov in the past week that are listed as recruiting and have at least one US site listed as recruiting, with facility, city, state, phase, conditions, lead sponsor and a link to the study record.
Does “newly posted” mean the study just started recruiting or added a site?
No. It means the study record was first posted in the past week and is listed as recruiting. Status changes and new sites will be listed only after we can compare weekly snapshots.
Is the recruiting status current?
It is the status listed on ClinicalTrials.gov as of the data date printed on each list. It may have changed since, so check the official record (the NCT link on each row) before you act on it.
How do I find newly recruiting clinical trials?
ClinicalTrials.gov is the official US registry, and you can search it by recruitment status, location and first-posted date. EnrollFeed runs that kind of search each week for new studies listed as recruiting with US sites and sends the result as one list grouped by state and lead sponsor, with a link to every record.
Can I use this to find clinical trial site leads?
It lists public study records: which sponsors posted new recruiting studies and which US facilities are listed as recruiting sites. It does not include contact details, and it does not promise meetings, contracts or enrollment. Check each record before any outreach.
Where does the data come from?
ClinicalTrials.gov, a U.S. government database. The sponsor or investigator is responsible for the accuracy of each record. This product is not affiliated with or endorsed by NIH, NLM, or ClinicalTrials.gov.
Do you include investigator or site contact details?
No. We do not include contact names, phone numbers or email addresses from the study records. When an individual investigator is the lead sponsor, we show “Individual investigator” with their institution instead of their name.
Is this medical or enrollment advice?
No. EnrollFeed is a business data list for research staffing firms, site networks and recruitment vendors. It is not medical or enrollment advice. If you are looking for a study to join, search ClinicalTrials.gov and talk with your doctor.
When is it delivered?
Weekly by email, Monday by default.
How much does it cost?
$149 per month for one recipient, or $299 per month for a team. There is no free tier. You can ask for a free one-week sample by emailing hello@enrollfeed.com.
How do billing and cancellation work?
Monthly, renewing automatically. Cancel anytime from the Stripe link in your receipt; cancellation takes effect at the end of the paid period. No refunds for partial months, but we refund your first charge if you ask within 7 days of it. US buyers only.